The robotic surgeon entered clinical trials.

The robotic surgeon entered clinical trials

The endoscopic surgical robot in the field of gynecology, developed by a Chinese company, entered the clinical trial phase, marking an important technological breakthrough in the domestic production of surgical robots.

The developer of the new robot is Edge Medical Robotics Co., Ltd. headquartered in Shenzhen. The company specializes in the design and manufacture of medical robotics.

With the help of the robot, gynecologists will be able to perform better operations. In addition, robotic surgery will reduce surgical trauma and complications after surgery, as well as speed up the patient’s recovery process.

Clinical trials of the new robot have begun at the General Hospital of the People’s Liberation Army of China in Beijing and the First Hospital of Zhengzhou University in Henan Province.

Wang Jianchen, CEO of Edge Medical Robotics, described the new development as an important step in the development of domestic medical technology. He noted that due to technological barriers, the Chinese surgical robot market has long been dominated by foreign products. “So far, only a few large hospitals in China have been able to acquire robotic surgeons for gynecological operations. The high costs make such robotic surgeries inaccessible to most patients, which limits the development of robotic surgery in China,” Wang Jianchen said.

“The domestically developed robotic surgeon has an advantage in terms of price-quality ratio in comparison with foreign counterparts and, accordingly, has great potential for operation in local medical institutions,” said Ji Mei, gynecologist at the First Hospital of Zhengzhou University. Ji Mei’s opinion is shared by the director of the gynecological department of the PLA General Hospital Meng Yuanguang. According to him, the use of such high-tech medical products in local medical institutions will allow more patients to benefit from high-quality medical care.

Share with friends: